US Stocks
/
Annovis Bio, Inc. Share Price

Annovis Bio, Inc. Share Price

NYSE: ANVS | Micro Cap
$1.18
-$0.04 (-3.28%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Annovis Bio, Inc. Stock Performance

Open
$1.15
Prev. Close
$1.22
Circuit Range
N/A
Day Range
$1.15 - $1.17
Year Range
$1.07 - $5.50
Volume
19,670
Average Traded
$1.15

Annovis Bio, Inc. Share Price Today

As of 9 October 2026, Annovis Bio, Inc.'s share price is $1.18. The stock opened at $1.15, compared to its previous close of $1.22. During today's trading session, Annovis Bio, Inc.'s share price traded between $1.15 and $1.17, with an average price of $1.16. Over the past 52 weeks, the stock has recorded a high of $5.50 and a low of $1.07. In terms of performance, Annovis Bio, Inc.'s share price has declined by 40.10% over the last six months and is down 43.54% on a year-on-year basis.

Annovis Bio, Inc. Share Price Chart

$1.15$1.17
L
Show Current Price
H

Annovis Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$24.25M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.16
Revenue (TTM)
$0.00
Return On Equity (TTM)
1164.01%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-104.13%

Annovis Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$7.26-$9.83-$17.61-$14.82
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-35.40%-79.15%15.84%

Annovis Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$25.33-$56.20-$24.59-$28.85
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-121.87%56.25%-17.32%

About Annovis Bio, Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Annovis Bio, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.26
$1.17
-8.59%
Sep 2026
$1.69
$1.28
-28.89%
Aug 2026
$1.75
$1.80
+2.86%
Jul 2026
$1.89
$1.75
-5.66%
Jun 2026
$1.96
$1.85
-3.39%
May 2026
$1.98
$1.92
-2.54%
Apr 2026
$2.26
$1.97
-11.26%
Mar 2026
$2.56
$2.22
-17.16%
Feb 2026
$2.70
$2.68
+0.00%
Jan 2026
$3.40
$2.68
-21.64%
Dec 2025
$5.09
$3.42
-32.94%
Nov 2025
$2.03
$5.10
+144.02%

ANVS Share Price FAQs

What is Annovis Bio, Inc. share price today?

chevron-up
Annovis Bio, Inc. share price today is $1.18 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Annovis Bio, Inc. stock?

chevron-up
The 52 week high of Annovis Bio, Inc. stock is $5.50, while the 52 week low is $1.07 as of 9 Oct '26.

What is ANVS's market capitalisation today?

chevron-up
ANVS market capitalisation is $24.25M as of October 9, 2026, at 4:46 pm IST.

What is ANVS's net income for the last quarter?

chevron-up
ANVS's net income for the last quarter is -14.82B USD.

What is the 5 year returns of ANVS?

chevron-up
The 5 year returns of ANVS is -95.49% as on 9 Oct '26.

What is the high & low stock price of ANVS today?

chevron-up
ANVS stock price hit a high of $1.17 and low of $1.15 as of 9 Oct '26.

Can I buy ANVS shares in India?

chevron-up
Yes. You can buy ANVS in India by opening an international trading account.